Latest News and Press Releases
Want to stay updated on the latest news?
-
AVITA Medical data at SRBC 2025 confirms RECELL® as standard of care, improving healing, reducing hospital stays, and lowering treatment costs
-
CMS grants NTAP for RECELL, adding up to $4,875 reimbursement for non-burn acute wounds, easing hospital costs and expanding patient access.
-
AVITA Medical has received the CE Mark for RECELL GO. This mark enables AVITA to begin commercializing RECELL GO across Europe.
-
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
Largest real-world RECELL study shows 6.2-day shorter hospital stays and $300 million in savings, presented at BBA 2025.
-
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
-
AVITA Medical expands portfolio with unique collagen dermal matrix through an exclusive development and distribution agreement with Regenity Biosciences.
-
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.